SYTE yields 36.43% · PFE yields 6.20%● Live data
📍 SYTE pulled ahead of the other in Year 1
Combined, SYTE + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SYTE + PFE for your $10,000?
Enterprise Diversified, Inc., together with its subsidiaries, engages in the Internet, asset management, real estate, and other businesses in the United States and Canada. The company operates four segments: Asset Management Operations, Real Estate Operations, Internet Operations, and Other Operations. It offers consumer and business-grade internet access; wholesale managed modem services for downstream internet service providers; web hosting services; third-party software as a reseller; and various ancillary services through Sitestar.net. The company also markets and sells narrow-band services, such as dial-up and ISDN; and broadband services comprising digital subscriber line, fiber-optic, and wireless services. The company was formerly known as Sitestar Corporation and changed its name to Enterprise Diversified, Inc. in July 2018. Enterprise Diversified, Inc. was incorporated in 1992 and is based in Richmond, Virginia.
Full SYTE Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.